Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Cloetta AB interim report Q4: October – December 2019

Continued growth in branded packaged products and improved profitability.• Net sales for the quarter increased by 4.6 per cent to SEK 1,722m (1,646) including a positive impact from foreign exchange rates of 2.0 per cent. • Operating profit amounted to SEK 209m (159). Profit for the period amounted to SEK 172m (159). Operating profit, adjusted for items affecting comparability, amounted to SEK 216m (174). • Cash flow from operating activities amounted to SEK 318m (288). • Net debt/EBITDA ratio was 2.2x (2.3). • The Board proposes a dividend of SEK 1.00 (1.00) per share.

Lagercrantz Interim Report 2019/20 Q3

Third quarter (1 October – 31 December 2019) · Net revenue increased by 9 percent to MSEK 1,099 (1,011). · Operating profit (EBITA) increased by 14 percent to MSEK 156 (137), equivalent to an operating margin of 14.2 percent (13.6). · Profit after financial items increased by 13 percent to MSEK 129 (114). · Profit after taxes increased by 19 percent to MSEK 105 (88). · Earnings per share after dilution for the latest 12-month period amounted to SEK 5.44 (SEK 5.05 for the 2018/19 financial year). · Return on equity for the latest 12-month period amounted to 25 percent (24)

Notice to Elisa’s Annual General Meeting

ELISA STOCK EXCHANGE RELEASE 29 JANUARY 2020 AT 9:00 AMNotice is given to the shareholders of Elisa Corporation (the "Company") of the Annual General Meeting to be held on Thursday, 2[ ]April 2020 at 2:00 pm at Messukeskus, the Expo & Convention Centre, Conference Centre Siipi, Rautatieläisenkatu 3, Helsinki. The reception of persons who have registered for the Meeting and the distribution of voting tickets will commence at 12:00 noon. Coffee is served between 12:00 noon and 2:00 pm. A. Matters on the agenda of the General Meeting 1. Opening of the Meeting 2. Calling the Meeting to

Promising results from human PK study assessing novel ketorolac formulations for treatment of pain

· OX338 demonstrated improved bioavailability and tolerability compared to commercially available reference product · Further work required to optimise product formulation Uppsala, Sweden – January 29, 2020. Orexo AB (publ.) today announces promising results from its OX338 pharmacokinetic study, evaluating novel formulations of ketorolac, a non-addictive, non-steroidal anti-inflammatory drug (NSAID) for the treatment of pain. Orexo’s OX338 formulations demonstrated improved bioavailability and tolerability compared to the commercially available reference product. In addition, one

Magnolia Bostad invites you to a conference call on 20 February with the publication of Year-end report for 2019

Magnolia Bostad is publishing its Year-end report for 2019, on 20 February at around 08:00 a.m. CET and invites you to a conference call at 10.30 CET on the same day.TeleconferenceInvestors, analysts, shareholders and the media are invited to the conference call:Date:  20 February 2020Time: 10.30 CET Fredrik Lidjan, CEO and Fredrik Westin, CFO, will comment on the results, and after this there will be time for questions. The conference call will be held in Swedish.To take part in the conference call and ask questions, please dial one of the following phone numbers:Sweden: +46 8

New Head of Business area Kockums

Saab has appointed Lars Tossman as the new head of business Area Kockums. Lars Tossman takes up the position on 1 February 2020 and will then also become a member of Saab Group Management.Lars Tossman joined Saab in 1986 and has held a number of positions within the company. Today, Lars Tossman is head of business unit Radar Solutions within business area Surveillance. Lars Tossman replaces Gunnar Wieslander, who left the position on January 24. For further information, please contact: Saab Press Centre, +46 (0)734 180 018, presscentre@saabgroup.com www.saabgroup.com www.

Loomis AB to publish Full-year Report on February 5, 2020

Loomis AB will publish the Full-year Report 2019 on Wednesday February 5, at 8:00 a.m. (CET).8.00 a.m. (CET) - Report releaseThe report will be sent as a press release from Cision (www.cision.se) and will automatically be published on www.loomis.com when released. 8:30 a.m. (CET) - Presentation slides availableFor presentation slides, go to www.loomis.com and choose “Financial presentation”. 9.00 a.m. (CET) – Telephone conference and audio castAnalysts and media are invited to participate in a telephone conference at 9:00 a.m. CET where Loomis President & CEO Patrik Andersson,

Full focus on future growth

January - December · Net sales increased 1.2 percent to SEK 307.6 (303.9) million (-4 percent in local currencies). · EBIT was SEK 6.2 (32.7) million. · The EBIT margin was 2.0 (10.8) percent. · Profit after tax amounted to SEK 4.9 (27.8) million. · Earnings per share amounted to SEK 0.28 (1.50). · Cash flow from operating activities amounted to SEK 17.7 (5.2) million. · Cash and cash equivalents at the end of the period amounted to SEK 63.9 (98.8) million. · The Board of Directors proposes that the AGM approves the distribution of dividends in the amount of SEK 0.

Elisa’s Financial Statements Release 2020

ELISA FINANCIAL STATEMENT RELEASE 29 JANUARY 2020 AT 8:30 AMFourth quarter 2019 financial highlights · Revenue increased by EUR 17m to EUR 487m, mainly due to the Polystar acquisition, growth in mobile services and equipment sales. · Mobile service revenue increased by 1.5 per cent to EUR 208m. · EBITDA, including the IFRS 16 change, grew by EUR 10m to EUR 168m. · EBIT, including the IFRS 16 change, increased by EUR 2m to EUR 100m. · Comparable cash flow decreased by EUR 2m to EUR 55m, mainly due to a change in net working capital, impacted by increased equipment sales. ·

YEAR-END REPORT 2019 – HiQ breaks the profit record, increased profit, increased margin and strong cash flow

Net sales during the year amounts to SEK 1 847.1 million. Operating profit for the same period increase by 15 per cent to SEK 226.1 (196.5) million. During the fourth quarter net sales amounts to SEK 491.3 (507.1) million, operating profit increases by 1 per cent to SEK 61.5 (61.2) million and operating margin increases to 12.5 (12.1) per cent. Cash flow for the fourth quarter of the year amounts to SEK 49.3 million and liquid assets total SEK 188.1 million. At the end of the quarter we are 1 560 employees at HiQ. The Board of HiQ proposes a dividend of SEK 3.40 per share, totalling SEK 190

Powerbox announces high peak load power supply for medical laser applications

Powerbox, one of Europe’s largest power supply companies, and for more than four decades a leading force in optimizing power solutions for demanding applications, has announced the release of its new power supply solution for high peak load applications in the medical sector. Based on digital control and high energy storage management techniques, the SMM3000A80024C series delivers 2.25kW repetitive peak power to medical lasers with high efficiency. The SMM3000A80024C complies with medical safety standards and for silent operation it includes a thermo-controlled cooling system.Laser

Hanne Katrama appointed Acting Head of Handelsbanken Finland

The Head of Handelsbanken Finland, Nina Arkilahti, has today announced that she will be leaving her position to pursue a career outside Handelsbanken. Following this decision, Hanne Katrama has been appointed as Acting Head of Handelsbanken Finland. She is currently Regional Area Manager in Finland and will take up her new position with immediate effect. The process to recruit a new permanent head of the Bank’s operations in Finland has already begun. For further information, please contact:Carina Åkerström, President and Group Chief Executive, tel: +46 (0)8 22 92 20Jan Larsson,

Winter’s new products from Fazer Bakery: Premium-quality Fazer Kiireetön bake-off bread arrives in shops, and Oululainen Jälkiuunipala gets thinner

We are bringing new premium-quality Fazer Kiireetön bread to bake-off units around Finland for friends of artisan bread to enjoy. Thin bread is becoming more popular in Finland and Oululainen Jälkiuuni is following trend: it is now thinner but still baked at a traditionally low temperature. This winter Finland's most popular rice pasties have an oat crust and families with children are introduced to a new oaty flatbread, Lemppari Kaurarieskanen.Fazer Kiireetön brings premium-quality bake-off bread to Finnish local shops Fazer Kiireetön bread always has a crisp crust, a succulent centre

Year-end report January–December 2019

Stable net sales in a tougher marketKEY HIGHLIGHTS · Strong net profit for the year and proposed increased dividend as a result of the successful divestment of Bergvik Skog Öst. · Fourth quarter sales volume growth offset by negative changes in pricing and mix due to weaker market conditions. · KM7 start-up impact in the fourth quarter in line with expectations. QUARTERLY DATA · Net sales were flat and amounted to SEK 5 815 million (5 843).   · Adjusted EBITDA* was SEK 618 million (810), negatively affected by KM7 start-up effects of around SEK 170 million. ·

Telia Company year-end report January-December 2019

CASH FLOW GROWTH Fourth quarter summary · Net sales like for like regarding exchange rates, acquisitions and disposals, declined 2.3 percent. Net sales in reported currency rose 2.8 percent to SEK 22,838 million (22,209). Service revenues like for like regarding exchange rates, acquisitions and disposals declined 1.7 percent. · Adjusted EBITDA excluding the positive impact from IFRS 16, like for like regarding exchange rates, acquisitions and disposals, grew by 4 percent. Like for like regarding exchange rates, acquisitions and disposals, adjusted EBITDA rose 14.7 percent.

SEB's fourth quarter 2019 result

The operating profit for the fourth quarter 2019 amounted to SEK 7.1bn with a return on equity of 15.5 per cent and a Common Equity Tier 1 capital ratio of 17.6 per cent. The Board of Directors proposes a dividend to the shareholders of SEK 6.25 per share. "This was yet another quarter of high client activity and we continued to grow across our home markets. Our diversified business model continued to serve us well and we benefited from the favourable financial markets. The operating profit rose by 22 per cent compared with the same period last year”, says Johan Torgeby, President and

Notice of Extraordinary General Meeting of Eniro AB (publ)

Welcome to the Extraordinary General Meeting (EGM) of Eniro AB (publ), corporate identity number 556588–0936, (“Eniro” or “the Company”), to be held on Monday 2 March 2020 at 15.00 in the premises of Helio, Kista Timebuilding, Kistagången 12, Kista, Sweden. Registration to the EGM and serving of coffee and cake will begin at 14.00. Participation A shareholder wishing to attend must: · be recorded as a shareholder in the shareholder register maintained by Euroclear Sweden AB on Tuesday 25 February 2020, and · give notice of attendance to the Company no later than Tuesday 25

Eniro AB presents a plan for recapitalisation involving an exchange of convertibles and bonds for preference shares of a new series A and calls for an Extraordinary General Meeting on 2 March 2020

This press release may not be announced, published or distributed, in whole or in part, directly or indirectly, in the United States, Canada, Japan, Australia, Hong Kong, New Zealand, Singapore, South Africa or any other country where such publication or distribution would violate applicable laws or rules or would require additional documents to be prepared or registered or require any other actions to be taken, in addition to the requirements under Swedish law. This press release is not a prospectus or an offer to subscribe, acquire or transfer shares, bonds or other securities. For further

Nordic Mining ASA: Key information relating to subsequent offering to be carried out by Nordic Mining ASA

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES (OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL). THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the stock exchange notice from Nordic Mining ASA (the "Company") earlier today, regarding a private placement of 28,700,000 new shares in the Company (the "Private Placement") and a subsequent offering of 10,000,000 new shares at the same

Nordic Mining ASA: Private Placement successfully completed

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES (OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL). THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.  Reference is made to the stock exchange release from Nordic Mining ASA ("Nordic Mining" or the "Company") published earlier today regarding the contemplated Private Placement.The Company is pleased to announce that it has raised approximately NOK 57.4 million in

Publication of Final Terms

Regulatory Announcement   Royal Bank of Canada January 28, 2020   Publication of Final Terms   Not for release, publication or distribution, directly or indirectly, in or into the United States.   Royal Bank of Canada has agreed to issue GBP1,250,000,000 Floating Rate Covered Bonds due January 30, 2025, Series CB49 (the "Covered Bonds") pursuant to the €32,000,000,000 Global Covered Bond Programme of Royal Bank of Canada, unconditionally and irrevocably guaranteed as to payments by RBC Covered Bond Guarantor Limited Partnership (the "Programme"). The following

Updated timetable for the clinical trial at Södersjukhuset

Calmark Sweden AB announces today that the timetable for the clinical trial underway at Södersjukhuset has been updated. The first patient was included on 23 December, and the rate of inclusion has thus far been lower than expected. The study is now estimated to be finished within six weeks. As a consequence, the Company's first product, Neo-Bilirubin, will obtain its CE conformity marking during the first quarter instead of in January as previously disclosed. This will not impact the market launch.The clinical trial shall include 40 children, and is designed as a method-comparison study,

There are no items matching the current filter
There are no more items matching the current filter
Back to top